-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 4, Jiangsu announced the province's third round of drug procurement plan (draft for comments), the key details of the manuscript have not yet been clarified, but the general outline
of this collective procurement can be roughly seen.
Scope of centralized procurement:
For unevaluated varieties that have been listed on the network in Jiangsu, the procurement cycle is at least 2 years
The range of varieties collected this time should be the varieties that have been hung on the net in Jiangsu but have not been evaluated, from which some varieties are screened out, and 80% of the stock (antibiotics are 70%) are taken out for volume procurement
.
The procurement cycle is two years, which can be extended by one year
if necessary.
Therefore, in theory, three years, three years can happen a lot of unexpected things, so enterprises should make careful decisions
.
The purchase price with volume has been linked to Jiangsu
Introducing alternative prices in Guangdong
The core part of the scheme is the selection rules, which are divided into exclusive and non-exclusive parts
.
Seeing this, the classification method of proprietary Chinese medicine and western medicine of Guangdong Alliance immediately came to mind, and sure enough, the limit price of Jiangsu's collective procurement this time absorbed alternative prices, and at a glance, it was known that it came from Guangdong, because this is the first in
Guangdong.
Limit price: Jiangsu listing price and the lowest price of national volume procurement (including alternative), the quotation of enterprises shall not be higher than the limit price
.
In addition to taking alternative prices into account, this article also shows that the volume purchase price has been linked to Jiangsu
.
Exclusive variety
If the quotation of exclusive varieties is not higher than the lowest price in the country, it is planned to be selected
Exclusive varieties selected in the lowest price provinces, with their own 80% intention volume; In the lowest-priced provinces, bring their own 30% intention volume, on this basis, for every 1% increase in the decrease, the proportion of the belt volume increases by 5%.
This volume-price linkage mechanism can be seen to be almost based on the rules of the Guangdong Alliance, and the alternative setting is gradually given according to the reduction rate, and there is a sense
of déjà vu of Cantonese-style roast goose embedded in Su-style mooncakes for filling.
Non-exclusive variety
Lowest TOP40% or 50% reduction
Enterprises in the same group meet one of the following conditions:
(1) According to the quotation from low to high, the top 40% of the enterprises in the same group (rounded up) are to be selected, and the number of selected enterprises in the same group shall not exceed 3
.
When the quotation is the same, the top ranking of the main business income of the pharmaceutical industry will be given priority (subject to the latest edition of the "China Pharmaceutical Statistics Annual Report" of the Ministry of Industry and Information Technology).
(2) If the reduction rate reaches 50%, the number of selected enterprises is not limited
.
The above two conditions, either the price in the lowest top 40% can be selected, or as long as the reduction reaches 50%, the number can be selected and the number is not limited
.
For non-exclusive unevaluated varieties, due to the large number of manufacturers and fierce competition, therefore, the selection rules only consider the price factor, simple and rude, conducive to the rapid landing of the policy, manufacturers are also good to consider the quotation, simply and crisply, do not drag mud and water
.
Carry out between/intra-group price correction and price balancing
After the results of the proposed selection are out, it is not over, and the price correction
must be carried out.
This practice is based on the practice of the seventh batch of national collective procurement, and also sets restrictions on the price between different varieties
.
The final quotation of the selected enterprise is divided into two methods for price correction: between-group correction and intra-group correction:
(1) Correction between groups
.
All non-exclusive varieties of the highest price of the proposed selected enterprises, according to the ratio of their final quotation to the lowest selected price of the same variety from high to low, the top 10% (rounded to the nearest round), should further reduce the price, so that the price difference ratio reaches the average price difference ratio of the remaining 90% of the selected enterprises
.
That is: the ratio of the highest price / the lowest price is sorted from high to low, and the top 10% have to reduce the price, how to reduce the price? If the spread ratio is consistent
with the average spread ratio of the last 90%.
Therefore, the average price spread of the bottom 90% of the selected enterprises is a key threshold, which plays a role
in balancing the overall non-exclusive variety price.
An inappropriate analogy is to use the average income ratio of the "poor" to balance the income level
of the richest Top10 people.
In addition to the above-mentioned between-group correction, there are also intra-group corrections:
(2) Correction within the group
.
If the number of selected enterprises in the same group reaches 2 or more, the products to be selected in the group should meet one of the following conditions:
a.
The price ≤ 1.
8 times the lowest price in the same group; b.
Reduction ≥ 50%; c.
The price of a single piece (grain/stick) ≤ 0.
1 yuan
.
Looking at these three conditions, there is a familiar recipe and familiar taste, which can float over through the computer screen
.
Isn't this the three conditions for the national drug procurement? Jiangsu collective procurement is directly used, but the national centralized procurement is a sufficient condition, and Jiangsu is a necessary condition, which shows that Jiangsu is active and practical
.
This correction method is to play a balancing role again on the price between enterprises in the same group, that is, the markup difference between everyone in the same group cannot exceed 1.
8 times, or the reduction rate needs to be more than 50%, or the absolute value of the price is within
1 cent.
So, what if there are companies that just don't agree to correct deviations? The scheme stipulates:
For the selected enterprises that do not accept the requirements for correcting the price of the proposed selection, the qualifications of the proposed selection will be cancelled and no longer replaced
.
The final price of the selected product is the final quotation
.
Flow label variety processing
Focus on monitoring and interviewing exclusive varieties, and add a round of bidding for non-exclusives
(1) Exclusive variety flow standard
.
The exclusive varieties of flow labels will be individually marked on the platform, and their procurement will be included in the key monitoring scope and reported
regularly.
When public medical institutions purchase flow-standard varieties, they shall report and explain it, and those who rank the highest in the amount of exclusive varieties purchased will be interviewed
.
The key monitoring + interview of the exclusive flow standard varieties can basically break the clinical use as before, and this trick may have the risk
of passive participation or even non-participation in collective procurement.
For non-exclusive bidding, adding a round of bidding is equivalent to giving an opportunity to ask each enterprise to carefully consider the consequences, because the plan stipulates that for non-exclusive varieties that are still bidding after re-bidding, the provincial platform with the lowest online price is proposed to be selected, and the rest of the enterprises will suspend the listing of the network
during the procurement cycle.
(2) Non-exclusive variety flow standard
.
Convection bid non-exclusive varieties, add a round of bidding, all enterprises of the same variety into a group of requotation, the lowest quotation and not higher than the national lowest price of this product and the online price of our province 1 enterprise to be selected, when the lowest quotation enterprise 2 or more, the provincial platform procurement volume in 2021 is preferred
。
Purchase volume allocation:
Lock in a lower 20% of the price allocated first
The remaining 60% of medical institutions choose independently
After the selected product is determined, the agreed purchase quantity of the exclusive variety can be allocated in accordance with the selection rules, and the key is the allocation of non-exclusive varieties, which directly determines the access and usage
of each subsequent selected enterprise in the hospital.
The allocation of non-exclusive varieties is divided into two steps:
The first step is to assign a priority amount
.
Medical institutions will take 20% of the intended purchase volume of the same variety as the priority quantity and allocate it to the top 50% of enterprises
with the lowest price of the same variety.
Please note that the first step is to get 20% of the hospital's intended purchase volume from the top 50% of the lowest price, which means that although the medical institution has a certain degree of independent choice, the first step must use 20% of the low-price enterprise, which is equivalent to locking in this part of the purchase volume and price, and the hospital has almost no choice
.
This is statutory
.
The second step is the margin of 60% (80% of the stock minus the allocated 20% in the first step), which is the part that the medical institution really has the right to choose, but it is still based on
the guidance of "high quality and affordability".
The second step is to allocate the remaining amount
.
Medical institutions can combine clinical needs and allocate 60% of the intended purchase quantity of the same variety as the remaining quantity to the selected products
of the same variety with high quality and reasonable price.
Jiangsu's allocation of procurement volume can be seen in the shadow of many centralized procurement projects, such as high-value consumables, insulin, and proprietary Chinese medicines
.
Peak shaving and valley filling + independent selection has become a mainstream distribution method
.
brief summary
1.
First of all, we should see that the procurement method with quantity is gradually replacing and replacing the hanging network procurement, and we can fully see this trend from the selection of some products from the unevaluated drugs in Jiangsu that have been listed on the network for volume procurement;
2, the price of volume procurement is linked, of course, this is not a new thing, from Beijing medicine, high-value consumables collection of volume linkage has begun to appear, to the third round of Jiangsu,Considering the lowest price of provincial and inter-provincial alliances as the key limit price indicator, this trend is more obvious;
3.
The third round of centralized drug procurement in Jiangsu has learned and absorbed the seventh batch of national centralized procurement and the practice of Guangdong Alliance collective procurement, and has its own ideas in terms of volume-price linkage and procurement volume allocation methods, which shows that the reference between various projects has obvious
role in promoting the next collective procurement project.
4.
Jiangsu considers the price correction factors, and at the same time has both the price balance relationship between and within the group, which plays a good role in stabilizing price expectations;
5.
Jiangsu's procurement volume allocation method not only locks in the selected products with low prices, but also gives medical institutions a certain right to
make independent choices.
Enterprises should fully see that collective procurement not only attaches importance to the quotation strategy at the access level, but also needs to report and manage the label at the clinical level
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body). 
